Nootropil (Piracetam)

Piracetam, the active ingredient in Nootropil, is a racetam (nootropic) presented as an oral tablet for oral use. It is used to support cognitive function and is prescribed for individuals with cognitive impairment, such as age‑related decline or post‑stroke deficits.

GNH USA supplies Nootropil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. All products are manufactured under GMP conditions and undergo rigorous testing before distribution.

Piracetam is a racetam nootropic that acts on cognitive pathways and neurological disorders. - Cognitive impairment: improves memory, attention and overall cognitive performance in age‑related decline or post‑stroke patients. - Myoclonus: reduces frequency and severity of involuntary muscle jerks associated with cortical myoclonus. - Vertigo: alleviates balance disturbances and dizziness in patients with vestibular disorders.

Piracetam is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Insomnia: difficulty initiating or maintaining sleep. - Nausea: occasional gastrointestinal upset. - Dizziness: sensation of light‑headedness. - Anxiety: increased nervousness or restlessness. - Gastrointestinal discomfort: abdominal pain or dyspepsia.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus or angioedema. - Hematologic disorders: thrombocytopenia or leukopenia. - Severe skin reactions: Stevens‑Johnson syndrome. - Seizures: rare occurrence in predisposed individuals. - Depression or mood changes: significant affective disturbances. - Liver enzyme elevation: abnormal hepatic function tests.

When prescribing piracetam, clinicians should consider several precautionary measures to ensure patient safety. - Renal function: adjust use in patients with severe renal impairment. - Hepatic function: monitor liver enzymes in long‑term therapy. - Elderly patients: start with lower doses due to increased sensitivity. - Pregnancy: use only if potential benefit justifies potential risk, as data are limited. - Concomitant CNS depressants: caution as additive sedation may occur. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Piracetam may interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Antiepileptic drugs (e.g., carbamazepine): reduced piracetam plasma levels. - Central nervous system depressants (e.g., alcohol, benzodiazepines): enhanced sedation.

Moderate Interactions (Monitor Closely): - Antihistamines: possible increase in drowsiness. - Other nootropics (e.g., aniracetam): additive cognitive effects. - Diuretics: may alter electrolyte balance, requiring monitoring.